A two-ingredient sublingual formulation listed for new customers. It omits GOLD’s apomorphine and oxytocin but still combines two PDE5 inhibitors.

MAX lists sildenafil 45 mg and tadalafil 18 mg. It differs from VMAX, which uses vardenafil with tadalafil, and from Sparks, which lists different strengths. These distinctions deserve more attention than similar duration headlines.

A simpler formula is still a combination

A combined product may be convenient, but response to one component cannot be assumed to predict response to both at the listed amounts. The clinician should explain why the pair is preferable for the individual.

The documented product is sildenafil 45 mg plus tadalafil 18 mg in a sublingual tablet. The listed delivery format is compounded sublingual tablet. FDA does not approve compounded finished products or verify their safety, effectiveness and quality before marketing. A licensed prescriber and pharmacy do not turn the compound into an FDA-approved product. FDA: Compounding and the FDA — questions and answers

Product
BlueChew MAX
Provider
BlueChew
Listed ingredients
Sildenafil 45 mg + tadalafil 18 mg
Format
Compounded sublingual tablet

What the advertised price actually buys

The provider’s cost article gives approximate examples from four monthly doses near $40 to twenty-four near $135. The lowest per-unit number belongs to a larger allocation, not necessarily the smallest payment. Confirm the pack and commitment.

Keep four numbers together: the amount due now, the quantity supplied, the period covered and the next renewal total. A monthly equivalent can make a prepaid plan look like a monthly bill. A low unit price can require a larger purchase. Neither figure tells you how often a medicine should be taken; only the prescription supplies those directions.

Approximate cost article
4 monthly doses around $40; 24 around $135
Separate unit headline
$5.63 needs its matching quantity confirmed
New-customer notice
MAX and GOLD named as options for new customers
Different from VMAX
MAX uses sildenafil, not vardenafil

What is supported—and what remains open

The tadalafil/sildenafil trial discussed in this publication studied separate daily and as-needed dosing. It did not test the MAX sublingual tablet, its onset clock or a head-to-head comparison with GOLD.

The evidence basis identified for this review is research on a different tadalafil/sildenafil regimen, not a MAX trial. The remaining uncertainty concerns matching onset endpoints and finished-formula comparative data. This distinction matters because a study can differ in strength, route, schedule, patient group or the outcome measured. A favorable result for one ingredient or regimen is not a clinical result for every product that shares its name.

Our review uses product and policy documents for commercial facts, and labels, government information and primary research for the medical context. We did not purchase or personally test this treatment, measure response times, or audit the provider’s clinical decisions. A missing matched study in this review is an evidence limit, not proof that a product never helps anyone.

The safety discussion this formula needs

PDE5 medicines can cause a dangerous blood-pressure drop with nitrates or nitrites, including recreational “poppers,” and must not be combined with riociguat. Tell the prescriber about all medicines, supplements, blood-pressure problems and heart conditions. Do not add another ED medicine or increase an amount based on an advertisement or this review. MedlinePlus: Sildenafil MedlinePlus: Tadalafil

Headache, flushing, indigestion, congestion and dizziness are among the adverse effects described for these medicines. The exact risk depends on the drug, prescription and medical history. A short list here cannot replace the complete pharmacy information or an individual assessment.

Overlapping ED medicines
The tadalafil label advises against use with other PDE5 inhibitors because combination safety and efficacy have not been established in labeling. A prescribed compound does not remove that uncertainty. DailyMed: Tadalafil prescribing information, including section 5.11

What the public listing does not settle

BlueChew MAX is classified here as “publicly listed.” Provider article lists a new-customer option; assessment required. A page being online does not verify shipping to every state, current stock, eligibility, or the formula that will be dispensed to a particular patient.

The source notice names MAX and GOLD for new customers. Medical eligibility and the actual prescription still require confirmation even when a product is in the current acquisition lineup.

Verify before ordering
Exact product name; complete ingredients and strengths; dispensing pharmacy; state access; clinician approval
Practical distinction
A safety document can describe an older formulation without confirming a current new-customer offer.

Refills, changes and cancellation

BlueChew distinguishes skipping one order from an indefinite hold. Its published cancellation policy asks for notice at least 24 hours before renewal, while the account FAQ asks for 48 hours for clinical plan changes. Those actions and deadlines are not interchangeable. A change does not alter an order already processing, and prescription returns are not accepted. Save the confirmation for the specific hold or cancellation requested, then check the next scheduled charge instead of assuming that a support conversation changed the account.

A customer-service action changes an account; a prescribing decision changes treatment. Keep both confirmations when changing plans. If symptoms or adverse effects require attention, contact the clinical team rather than waiting for the next scheduled billing event. BlueChew: account and subscription questions · BlueChew: shipping and delivery questions · BlueChew: returns and refunds policy

Compare the products that differ in a meaningful way

A useful next comparison for BlueChew MAX changes one identifiable feature: the ingredient combination, the dosage form, the schedule or the provider’s commercial terms. The related reviews below make those differences visible. They are not a clinical ranking or a recommendation to substitute medicines.

Use the comparison desk to place up to three fact sheets together. The plan-cost guide explains why comparing a monthly equivalent with a per-dose headline can produce the wrong conclusion.

Questions to take to the consultation

What is the intended benefit of combining these two ingredients at the prescribed strengths?

Also ask what would count as a useful response, what side effects should prompt contact, who reviews an unsatisfactory result, and how a change reaches the pharmacy before the next order. Keep the answer tied to this exact prescription, not the provider’s product family.

Prescription question
Why this ingredient list, strength, route and schedule for the symptoms discussed?
Payment question
What is charged today, what renews, and when does cancellation need to be recorded?
Follow-up question
How do I reach a clinician, and what should be handled through urgent or emergency care?

When account support is not enough

Seek emergency care for an erection lasting more than four hours or chest pain. Tell the treating team which medicines were taken and when. Sudden loss of vision or hearing needs prompt medical attention; do not wait for a routine subscription-support reply. MedlinePlus: Sildenafil MedlinePlus: Tadalafil

Read the underlying material

Sources & evidence notes

Provider documents support product and commercial details. Clinical references have their own study or labeling limits. Accessed October 7, 2026; indexed abstracts were used for the listed studies.

  1. BlueChew: product-specific approximate costs

    Provider price examples; approximate and not necessarily consistent with other offer pages

  2. BlueChew: combination and single-ingredient formulas

    Provider article; listed strengths and formulations, not independent comparative evidence

  3. BlueChew: product access and legacy-plan notice

    Provider article; restricts certain products to existing enrolled customers; confirm account eligibility

  4. BlueChew: account and subscription questions

    Provider policy; plan changes, one-order skips, and indefinite holds

  5. BlueChew: shipping and delivery questions

    Provider policy; destination availability, shipping, and renewal terms

  6. BlueChew: returns and refunds policy

    Provider policy; prescription returns and 24-hour cancellation notice

  7. EAU: Management of erectile dysfunction

    Specialty guideline; clinical evaluation, treatment, and limited combination evidence

  8. Cui et al. (2015): daily tadalafil with as-needed sildenafil

    Primary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI

  9. MedlinePlus: Tadalafil

    Drug information; standard tadalafil products

  10. DailyMed: Tadalafil prescribing information, including section 5.11

    Prescribing label; not evidence for the 4Play combination

  11. FDA: Compounding and the FDA — questions and answers

    Government guidance on compounded medications

  12. MedlinePlus: Sildenafil

    Drug information; standard sildenafil products